South Korea
· Delayed Price · Currency is KRW CORESTEMCHEMON Statistics
Total Valuation
CORESTEMCHEMON has a market cap or net worth of KRW 320.59 billion. The enterprise value is 352.37 billion.
| Market Cap | 320.59B |
| Enterprise Value | 352.37B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CORESTEMCHEMON has 23.56 million shares outstanding. The number of shares has increased by 15.85% in one year.
| Shares Outstanding | 23.56M |
| Shares Change (YoY) | +15.85% |
| Shares Change (QoQ) | +6.93% |
| Owned by Insiders (%) | 16.77% |
| Owned by Institutions (%) | 0.08% |
| Float | 19.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.78 |
| PB Ratio | 16.53 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.17 |
| EV / Sales | 11.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.14 |
Financial Position
The company has a current ratio of 0.31, with a Debt / Equity ratio of 1.95.
| Current Ratio | 0.31 |
| Quick Ratio | 0.18 |
| Debt / Equity | 1.95 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.09 |
| Interest Coverage | -5.67 |
Financial Efficiency
Return on equity (ROE) is -135.91% and return on invested capital (ROIC) is -24.65%.
| Return on Equity (ROE) | -135.91% |
| Return on Assets (ROA) | -15.26% |
| Return on Capital (ROIC) | -24.65% |
| Revenue Per Employee | 85.72M |
| Profits Per Employee | -97.59M |
| Employee Count | 355 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 49.39 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +127.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +127.20% |
| 50-Day Moving Average | 11,335.40 |
| 200-Day Moving Average | 10,410.40 |
| Relative Strength Index (RSI) | 65.79 |
| Average Volume (20 Days) | 249,299 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CORESTEMCHEMON had revenue of KRW 30.43 billion and -34.65 billion in losses. Loss per share was -1,724.47.
| Revenue | 30.43B |
| Gross Profit | 501.97M |
| Operating Income | -22.70B |
| Pretax Income | -34.58B |
| Net Income | -34.65B |
| EBITDA | -17.66B |
| EBIT | -22.70B |
| Loss Per Share | -1,724.47 |
Balance Sheet
The company has 6.00 billion in cash and 37.78 billion in debt, giving a net cash position of -31.78 billion or -1,349.10 per share.
| Cash & Cash Equivalents | 6.00B |
| Total Debt | 37.78B |
| Net Cash | -31.78B |
| Net Cash Per Share | -1,349.10 |
| Equity (Book Value) | 19.39B |
| Book Value Per Share | 823.22 |
| Working Capital | -37.96B |
Cash Flow
In the last 12 months, operating cash flow was -17.36 billion and capital expenditures -17.37 billion, giving a free cash flow of -34.74 billion.
| Operating Cash Flow | -17.36B |
| Capital Expenditures | -17.37B |
| Free Cash Flow | -34.74B |
| FCF Per Share | -1,474.60 |
Margins
Gross margin is 1.65%, with operating and profit margins of -74.59% and -113.85%.
| Gross Margin | 1.65% |
| Operating Margin | -74.59% |
| Pretax Margin | -113.64% |
| Profit Margin | -113.85% |
| EBITDA Margin | -58.04% |
| EBIT Margin | -74.59% |
| FCF Margin | -114.14% |
Dividends & Yields
CORESTEMCHEMON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.85% |
| Shareholder Yield | -15.85% |
| Earnings Yield | -12.67% |
| FCF Yield | -10.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CORESTEMCHEMON has an Altman Z-Score of -0.89. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.89 |
| Piotroski F-Score | n/a |